Prevalence of high risk symptoms according NICE Guideline criteria by PPI use.</p
Each entry in the Low, Mean and High columns is the mean and 95% confidence interval of 30 runs.</p
Levels of evidence for recommendations for SSI prevention as reported in included CPGs.</p
Prevalence ratio (PR) and 95% confidence interval (CI) for the association between distress and mult...
Risk of PPI exposure for pancreatic cancer (case) development among various risk groups (reference: ...
<p>Risk of exposure to PPI for CRC development among various risk groups (reference: PPI use <60 dai...
The PPV and NPV reported when using two different prevalence values, one for the general population ...
The prevalence of non-compliant medicines grouped according to different criteria.</p
<p>Prevalence and unadjusted risk of Oral Potentially Malignant Disorders by major lifestyles.</p
<p>High-risk PC statistics against genotype, smoking status and PSA interval among study groups.</p
<p>OR: Odds Ratio, PPV: Positive Predictive Value, NPV: Negative Predictive Value</p><p>Symptom dist...
<p>Impetigo prevalence and severity (AOR: adjusted odds ratio; CI: confidence interval).</p
Adjusted hazard ratios (HR) and 95% confidence interval (CI) for residential care admission in the h...
Prevalence of adverse events (AEs) and serious adverse events (SAEs) before and after CBPP protocol ...
<p>Disease and symptom prevalence estimates including 95% confidence intervals and unadjusted odds r...
Demographic and clinical characteristics and endoscopic findings of patients according to PPI use.</...
Each entry in the Low, Mean and High columns is the mean and 95% confidence interval of 30 runs.</p
Levels of evidence for recommendations for SSI prevention as reported in included CPGs.</p
Prevalence ratio (PR) and 95% confidence interval (CI) for the association between distress and mult...
Risk of PPI exposure for pancreatic cancer (case) development among various risk groups (reference: ...
<p>Risk of exposure to PPI for CRC development among various risk groups (reference: PPI use <60 dai...
The PPV and NPV reported when using two different prevalence values, one for the general population ...
The prevalence of non-compliant medicines grouped according to different criteria.</p
<p>Prevalence and unadjusted risk of Oral Potentially Malignant Disorders by major lifestyles.</p
<p>High-risk PC statistics against genotype, smoking status and PSA interval among study groups.</p
<p>OR: Odds Ratio, PPV: Positive Predictive Value, NPV: Negative Predictive Value</p><p>Symptom dist...
<p>Impetigo prevalence and severity (AOR: adjusted odds ratio; CI: confidence interval).</p
Adjusted hazard ratios (HR) and 95% confidence interval (CI) for residential care admission in the h...
Prevalence of adverse events (AEs) and serious adverse events (SAEs) before and after CBPP protocol ...
<p>Disease and symptom prevalence estimates including 95% confidence intervals and unadjusted odds r...
Demographic and clinical characteristics and endoscopic findings of patients according to PPI use.</...
Each entry in the Low, Mean and High columns is the mean and 95% confidence interval of 30 runs.</p
Levels of evidence for recommendations for SSI prevention as reported in included CPGs.</p
Prevalence ratio (PR) and 95% confidence interval (CI) for the association between distress and mult...
DOI
Add to ORKG